Sandoz Group AG (SDZNY)
42.38
1.40 (3.42%)
At close: Apr 25, 2025, 3:57 PM
3.42% (1D)
| Bid | 42.31 |
| Market Cap | 18.25B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.02 |
| PE Ratio (ttm) | -2119.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 42.45 |
| Volume | 3,572 |
| Avg. Volume (20D) | 44,201.3 |
| Open | 40.93 |
| Previous Close | 40.98 |
| Day's Range | 40.93 - 42.45 |
| 52-Week Range | 32.48 - 49.81 |
| Beta | 0.41 |
About SDZNY
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. ...
Sector Healthcare
IPO Date Oct 4, 2023
Employees 22,049
Stock Exchange PNK
Ticker Symbol SDZNY
Website https://www.sandoz.com
